Intra-Articular Joint Injections Guideline

Contraindications and Precautions

Intra-articular joint injections are contraindicated in cases of active joint infection, overlying skin infection, bacteremia, and should be avoided in prosthetic joints except when performed by orthopedic surgeons after careful screening for prosthetic infection 1
Patients with known hypersensitivity to the injectable agent should not receive intra-articular joint injections to prevent allergic reactions 1
Patients with diabetes, especially those with suboptimal control, should be informed about the risk of transient hyperglycemia following glucocorticoid injections and blood glucose monitoring is recommended from the first to third day post-injection 1

Injections should be performed at least 3 months prior to planned joint replacement surgery to minimize infection risk 1
Patients should avoid overuse of injected joints for 24 hours following injection and complete immobilization is not recommended and may be counterproductive 1

The generally accepted guideline is to limit glucocorticoid injections to 3-4 per joint per year to prevent cartilage damage and systemic effects, with a minimum of 7 days between injections 1
Proper skin preparation with alcohol, iodine disinfectant or chlorhexidine is essential to prevent infection 1

Patients should be warned about potential post-injection flare of pain, which is usually self-limiting within 24-48 hours 1
Diabetic patients should be advised to monitor their blood glucose levels from the first to third day post-injection to prevent uncontrolled hyperglycemia 1
Patients on anticoagulation therapy should be cautioned, and their INR levels and bleeding risk should be considered before proceeding 1
The European League Against Rheumatism (EULAR) guidelines note that intra-articular injections can provide significant pain relief, though high-quality studies evaluating long-term effects are limited 1
Repeat injections are medically necessary for patients with documented >50% pain relief for more than 3 months following the previous injection, with a maximum of 4 injections per year, as per Aetna's Clinical Policy Bulletin 1
Post-procedure care should include avoiding overuse of the injected joints for 24 hours following injection, though complete immobilization is not recommended, as suggested by clinical guidelines 2, 1